Cargando…

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol

INTRODUCTION: Early phase dose-finding (EPDF) studies are critical for the development of new treatments, directly influencing whether compounds or interventions can be investigated in further trials to confirm their safety and efficacy. There exists guidance for clinical trial protocols and reporti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinasse, Aude, Solovyeva, Olga, Dimairo, Munyaradzi, Weir, Christopher, Jaki, Thomas, Mander, Adrian, Kightley, Andrew, Evans, Jeffry, Lee, Shing, Bedding, Alun, Hopewell, Sally, Rantell, Khadija, Liu, Rong, Chan, An-Wen, De Bono, Johann, Yap, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Medical Publishing and Peer Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069529/ https://www.ncbi.nlm.nih.gov/pubmed/36990492 http://dx.doi.org/10.1136/bmjopen-2022-068173

Ejemplares similares

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
por: Solovyeva, Olga, et al.
Publicado: (2023)

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
por: Yap, Christina, et al.
Publicado: (2023)

Protocol of the CONSORT and SPIRIT Extension for multicenter clinical trials
por: Zhang, Xuan, et al.
Publicado: (2023)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2018)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
por: Dimairo, Munyaradzi, et al.
Publicado: (2020)

Protocol for CONSORT-SPI: an extension for social and psychological interventions
por: Montgomery, Paul, et al.
Publicado: (2013)

CONSORT 2010 statement: extension to randomised pilot and feasibility trials
por: Eldridge, Sandra M., et al.
Publicado: (2016)

CONSORT 2010 statement: extension to randomised pilot and feasibility trials
por: Eldridge, Sandra M, et al.
Publicado: (2016)

How to design a dose-finding study using the continual reassessment method
por: Wheeler, Graham M., et al.
Publicado: (2019)

Improving the reporting of randomised pilot and feasibility studies: a consort statement extension
por: Eldridge, Sandra, et al.
Publicado: (2015)

Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension
por: Montgomery, Paul, et al.
Publicado: (2018)

Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Implications of the artificial intelligence extensions to the guidelines for consolidated standards of reporting trials and for standard protocol item recommendations for interventional trials (the CONSORT-AI and SPIRIT-AI extensions)
por: Solebo, Ameenat Lola, et al.
Publicado: (2020)

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials
por: Grayling, Michael J, et al.
Publicado: (2019)

Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials
por: Thabane, Lehana, et al.
Publicado: (2016)

On the Extension and Increase of the Scientific Spirit in Medicine
por: Duncan, J. Matthews
Publicado: (1874)

Erratum to: Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials
por: Thabane, Lehana, et al.
Publicado: (2016)

Improving the reporting of pragmatic trials: an extension of the CONSORT statement
por: Zwarenstein, Merrick, et al.
Publicado: (2008)

CONSORT 2010 statement: extension to randomised crossover trials
por: Dwan, Kerry, et al.
Publicado: (2019)

Innovative considerations on a phase 2a dose-finding strategy using Bayesian methods and MCP-MOD
por: Bedding, Alun, et al.
Publicado: (2015)

Investigation of the shortcomings of the consort 2010 statement for the reporting of group sequential randomised controlled trials
por: Dimairo, Munyaradzi, et al.
Publicado: (2015)

A benchmark for dose-finding studies with unknown ordering
por: Mozgunov, Pavel, et al.
Publicado: (2021)

Reporting Quality of Journal Abstracts for Surgical Randomized Controlled Trials Before and After the Implementation of the CONSORT Extension for Abstracts
por: Speich, Benjamin, et al.
Publicado: (2019)

Principles of dose finding studies in cancer: a comparison of trial designs
por: Jaki, Thomas, et al.
Publicado: (2013)

CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
Publicado: (2016)

Introducing the new CONSORT extension for stepped-wedge cluster randomised trials
por: Hemming, Karla, et al.
Publicado: (2019)

An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
por: Stevely, Abigail, et al.
Publicado: (2015)

Adaptive dose-finding designs to identify multiple doses that achieve multiple response targets
por: Bond, Simon, et al.
Publicado: (2013)

P05.50. CONSORT extension for N-of-1 trials (CENT) guidelines
por: Shamseer, L, et al.
Publicado: (2012)

The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice
por: Calvert, Melanie, et al.
Publicado: (2013)

Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements
por: Cheng, Adam, et al.
Publicado: (2016)

CONSORT 2010 statement: extension checklist for reporting within person randomised trials
por: Pandis, Nikolaos, et al.
Publicado: (2017)

CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
por: Kwakkenbos, Linda, et al.
Publicado: (2021)

Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs
por: Barnett, Helen, et al.
Publicado: (2022)

Suburethral Endometriosis as Clinical Finding of Extensive Disease
por: Nezhat, Ceana H., et al.
Publicado: (2022)

Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2022)

A dose-finding design for dual-agent trials with patient-specific doses for one agent with application to an opiate detoxification trial
por: Mozgunov, Pavel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kol56c6hnu5kimavpstcu97mp9